Clinical Trial Update: Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluating the combination of Triamcinolone and Nepafenac for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Nepafenac (nepafenac)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED